It’s hard to believe it’s already been 7 months since the last Miami Breast Cancer Conference®. Seven months since we last gathered at the Fontainebleau in Miami Beach for 4 days of learning and celebrating the latest in breast cancer research.
2018 has already been quite the year for new data, most of which has revolved around one theme: the de-escalation of therapy. At the most recent meeting in Chicago we first heard the latest results from trials such as TAILORx and PERSPEHONE, which are already changing the way we treat patients with early-stage breast cancer.
As exciting a time this is, with every new trial comes new questions. How the latest data impacts your practice and your patients requires a careful understanding of new data, that takes a multidisciplinary perspective into account.
The Miami Breast Cancer Conference® is a meeting uniquely positioned to provide that perspective. With faculty and learners of complex and differing backgrounds, someone in Miami will always be able to answer your questions and help with your most difficult cases. Whether it was first reported at a major meeting or the supplement of a journal, what you need to know, and how to use it, will be presented at Miami.
I can’t wait to see you there!
Patrick I. Borgen, MD